Based on recent headline ratings, % of this readership currently trusts the local media, which has an average score of % regionally and is currently trending .
Media Trust Score%

KayoThera, Inc. Nominates First-in-Class, Oral Inhibitor of the Retinoid Pathway … – PharmiWeb.com

Unique safety profile positions KAYO-1609 as the first retinoid pathway inhibitor to enter Investigational New Drug (IND)-enabling studiesCompany …

  • You already voted!
  • Full Article

    About the Score

    Based on recent headline ratings, % of this readership currently trusts the local media, which has an average score of % regionally and is currently trending .

    Media Trust Score%